The endometriotic tumor microenvironment in ovarian cancer

Jillian R. Hufgard Wendel, Xiyin Wang, Shannon Hawkins

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Women with endometriosis are at increased risk of developing ovarian cancer, specifically ovarian endometrioid, low-grade serous, and clear-cell adenocarcinoma. An important clinical caveat to the association of endometriosis with ovarian cancer is the improved prognosis for women with endometriosis at time of ovarian cancer staging. Whether endometriosis-associated ovarian cancers develop from the molecular transformation of endometriosis or develop because of the endometriotic tumor microenvironment remain unknown. Additionally, how the presence of endometriosis improves prognosis is also undefined, but likely relies on the endometriotic microenvironment. The unique tumor microenvironment of endometriosis is composed of epithelial, stromal, and immune cells, which adapt to survive in hypoxic conditions with high levels of iron, estrogen, and inflammatory cytokines and chemokines. Understanding the unique molecular features of the endometriotic tumor microenvironment may lead to impactful precision therapies and/or modalities for prevention. A challenge to this important study is the rarity of well-characterized clinical samples and the limited model systems. In this review, we will describe the unique molecular features of endometriosis-associated ovarian cancers, the endometriotic tumor microenvironment, and available model systems for endometriosis-associated ovarian cancers. Continued research on these unique ovarian cancers may lead to improved prevention and treatment options.

Original languageEnglish (US)
Article number261
JournalCancers
Volume10
Issue number8
DOIs
StatePublished - Aug 1 2018

Fingerprint

Tumor Microenvironment
Endometriosis
Ovarian Neoplasms
Clear Cell Adenocarcinoma
Neoplasm Staging
Stromal Cells
Chemokines
Estrogens
Iron
Cytokines

Keywords

  • Endometriosis
  • Genes
  • Hypoxia
  • Inflammation
  • miRNA molecules
  • Model systems
  • Ovarian cancer
  • Tumor microenvironment

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

The endometriotic tumor microenvironment in ovarian cancer. / Hufgard Wendel, Jillian R.; Wang, Xiyin; Hawkins, Shannon.

In: Cancers, Vol. 10, No. 8, 261, 01.08.2018.

Research output: Contribution to journalReview article

Hufgard Wendel, Jillian R. ; Wang, Xiyin ; Hawkins, Shannon. / The endometriotic tumor microenvironment in ovarian cancer. In: Cancers. 2018 ; Vol. 10, No. 8.
@article{e9d86b2916b941f18793d937490a62f5,
title = "The endometriotic tumor microenvironment in ovarian cancer",
abstract = "Women with endometriosis are at increased risk of developing ovarian cancer, specifically ovarian endometrioid, low-grade serous, and clear-cell adenocarcinoma. An important clinical caveat to the association of endometriosis with ovarian cancer is the improved prognosis for women with endometriosis at time of ovarian cancer staging. Whether endometriosis-associated ovarian cancers develop from the molecular transformation of endometriosis or develop because of the endometriotic tumor microenvironment remain unknown. Additionally, how the presence of endometriosis improves prognosis is also undefined, but likely relies on the endometriotic microenvironment. The unique tumor microenvironment of endometriosis is composed of epithelial, stromal, and immune cells, which adapt to survive in hypoxic conditions with high levels of iron, estrogen, and inflammatory cytokines and chemokines. Understanding the unique molecular features of the endometriotic tumor microenvironment may lead to impactful precision therapies and/or modalities for prevention. A challenge to this important study is the rarity of well-characterized clinical samples and the limited model systems. In this review, we will describe the unique molecular features of endometriosis-associated ovarian cancers, the endometriotic tumor microenvironment, and available model systems for endometriosis-associated ovarian cancers. Continued research on these unique ovarian cancers may lead to improved prevention and treatment options.",
keywords = "Endometriosis, Genes, Hypoxia, Inflammation, miRNA molecules, Model systems, Ovarian cancer, Tumor microenvironment",
author = "{Hufgard Wendel}, {Jillian R.} and Xiyin Wang and Shannon Hawkins",
year = "2018",
month = "8",
day = "1",
doi = "10.3390/cancers10080261",
language = "English (US)",
volume = "10",
journal = "Cancers",
issn = "2072-6694",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "8",

}

TY - JOUR

T1 - The endometriotic tumor microenvironment in ovarian cancer

AU - Hufgard Wendel, Jillian R.

AU - Wang, Xiyin

AU - Hawkins, Shannon

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Women with endometriosis are at increased risk of developing ovarian cancer, specifically ovarian endometrioid, low-grade serous, and clear-cell adenocarcinoma. An important clinical caveat to the association of endometriosis with ovarian cancer is the improved prognosis for women with endometriosis at time of ovarian cancer staging. Whether endometriosis-associated ovarian cancers develop from the molecular transformation of endometriosis or develop because of the endometriotic tumor microenvironment remain unknown. Additionally, how the presence of endometriosis improves prognosis is also undefined, but likely relies on the endometriotic microenvironment. The unique tumor microenvironment of endometriosis is composed of epithelial, stromal, and immune cells, which adapt to survive in hypoxic conditions with high levels of iron, estrogen, and inflammatory cytokines and chemokines. Understanding the unique molecular features of the endometriotic tumor microenvironment may lead to impactful precision therapies and/or modalities for prevention. A challenge to this important study is the rarity of well-characterized clinical samples and the limited model systems. In this review, we will describe the unique molecular features of endometriosis-associated ovarian cancers, the endometriotic tumor microenvironment, and available model systems for endometriosis-associated ovarian cancers. Continued research on these unique ovarian cancers may lead to improved prevention and treatment options.

AB - Women with endometriosis are at increased risk of developing ovarian cancer, specifically ovarian endometrioid, low-grade serous, and clear-cell adenocarcinoma. An important clinical caveat to the association of endometriosis with ovarian cancer is the improved prognosis for women with endometriosis at time of ovarian cancer staging. Whether endometriosis-associated ovarian cancers develop from the molecular transformation of endometriosis or develop because of the endometriotic tumor microenvironment remain unknown. Additionally, how the presence of endometriosis improves prognosis is also undefined, but likely relies on the endometriotic microenvironment. The unique tumor microenvironment of endometriosis is composed of epithelial, stromal, and immune cells, which adapt to survive in hypoxic conditions with high levels of iron, estrogen, and inflammatory cytokines and chemokines. Understanding the unique molecular features of the endometriotic tumor microenvironment may lead to impactful precision therapies and/or modalities for prevention. A challenge to this important study is the rarity of well-characterized clinical samples and the limited model systems. In this review, we will describe the unique molecular features of endometriosis-associated ovarian cancers, the endometriotic tumor microenvironment, and available model systems for endometriosis-associated ovarian cancers. Continued research on these unique ovarian cancers may lead to improved prevention and treatment options.

KW - Endometriosis

KW - Genes

KW - Hypoxia

KW - Inflammation

KW - miRNA molecules

KW - Model systems

KW - Ovarian cancer

KW - Tumor microenvironment

UR - http://www.scopus.com/inward/record.url?scp=85051389056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051389056&partnerID=8YFLogxK

U2 - 10.3390/cancers10080261

DO - 10.3390/cancers10080261

M3 - Review article

VL - 10

JO - Cancers

JF - Cancers

SN - 2072-6694

IS - 8

M1 - 261

ER -